Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition

References

• Auzenne E, Ghosh SC, Khodadadian M, et al. (2007). Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 9:479–86
   PubMed Web of Science ®Google Scholar
• Camenisch TD, McDonald JA. (2000). Hyaluronan: is bigger better? Am J Respir Cell Mol Biol 3:431–3
   Web of Science ®Google Scholar
• Chen D, Jiang X, Liu J, et al. (2010). In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Artif Cells Blood Substit Immobil Biotechnol 38:136–42
   PubMed Web of Science ®Google Scholar
• Chen D, Liu W, Shen Y, et al. (2011). Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomed 6:2053–61
   PubMed Web of Science ®Google Scholar
• Chen D, Sun K, Mu H, et al. (2012). pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomed 7:2621–30
   PubMed Web of Science ®Google Scholar
• Chen D, Mu H, Sun K, Liu W. (2013). Synthesis, anticoagulant activity and potential drug carrier of biomimetic N-cholesteryl hemisuccinate-O-sulfate chitosan polymer of blood cell membrane. J Contr Rel 172:e25
   Web of Science ®Google Scholar
• Chen D, Wang H. (2014). Novel pH-sensitive biodegradable polymeric drug delivery systems based on ketal polymers. J Nanosci Nanotechnol 14:983–9
   PubMed Web of Science ®Google Scholar
• Choi KY, Min KH, Yoon HY, et al. (2011). PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32:1880–9
   PubMed Web of Science ®Google Scholar
• Coradini D, Zorzet S, Rossin R, et al. (2004). Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. Clin Cancer Res 10:4822–30
   PubMed Web of Science ®Google Scholar
• Eliaz RE, Nir S, Marty C, Szoka FC Jr. (2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64:711–18
   PubMed Web of Science ®Google Scholar
• Gerecht S, Burdick JA, Ferreira LS, et al. (2007). Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104:11298–303
   PubMed Web of Science ®Google Scholar
• Götte M, Yip GW. (2006). Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233–7
   PubMed Web of Science ®Google Scholar
• Jaracz S, Chen J, Kuznetsova LV, Ojima I. (2005). Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 13:5043–54
   PubMed Web of Science ®Google Scholar
• Kothapalli D, Flowers J, Xu T, et al. (2008). Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 283:31823–9
   PubMed Web of Science ®Google Scholar
• Lee H, Mok H, Lee S, et al. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Contr Rel 119:245–52
   PubMed Web of Science ®Google Scholar
• Morra M. (2005). Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 6:1205–23
   PubMed Web of Science ®Google Scholar
• Peer D, Margalit R. (2004). Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer 108:780–9
   PubMed Web of Science ®Google Scholar
• Sleeman J, Rudy W, Hofmann M, et al. (1996). Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 135:1139–50
   PubMed Web of Science ®Google Scholar
• Slevin M, Krupinski J, Gaffney J, et al. (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26:58–68
   PubMed Web of Science ®Google Scholar
• Stern R, Asari AA, Sugahara KN. (2006). Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85:699–715
   PubMed Web of Science ®Google Scholar
• Toole BP. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–39
   PubMed Web of Science ®Google Scholar
• Yang C, Cao M, Liu H, et al. (2012). The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287:43094–107
   PubMed Web of Science ®Google Scholar
• Yu H, Mu H, Xiu L, et al. (2013). A novel ketal-based chitosan as nano-vehicles for potential ph-sensitive nanomedicine delivery. Nanosci Nanotechnol Lett 5:1007–11
   Web of Science ®Google Scholar